Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMPARİSON OF THE EFFECTS OF ULTRASOUND-GUİDED PREOPERATİVE SHOULDER POSTERİOR PERİCAPSULAR NERVE GROUP (SPENG) BLOCK AND SUPERİOR TRUNK BLOCK ON DİAPHRAGMATİC FUNCTİON, INTRAOPERATİVE MECHANİCAL POWER, NOCİCEPTİON (QNOX), AND POSTOPERATİVE ANALGESİA İN UPPER EXTREMİTY AND SHOULDER SURGERY: A PROSPECTİVE RANDOMİZED CONTROLLED TRİAL

NCT07936435 is registered in ClinicalTrials.gov with Bursa Yuksek Ihtisas Training and Research Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07936435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
COMPARİSON OF THE EFFECTS OF ULTRASOUND-GUİDED PREOPERATİVE SHOULDER POSTERİOR PERİCAPSULAR NERVE GROUP (SPENG) BLOCK AND SUPERİOR TRUNK BLOCK ON DİAPHRAGMATİC FUNCTİON, INTRAOPERATİVE MECHANİCAL POWER, NOCİCEPTİON (QNOX), AND POSTOPERATİVE ANALGESİA İN UPPER EXTREMİTY AND SHOULDER SURGERY: A PROSPECTİVE RANDOMİZED CONTROLLED TRİAL
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
September 1, 2027
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

humerus fractures, shoulder arthroscopic surgery, upper extremity

Arms

As registered; 2 arms.

  • SPENG Block ExperimentalSPENG Block

    Participants will receive an ultrasound-guided Shoulder Posterior Pericapsular Nerve Group (SPENG) block with 20 mL of 0.25% bupivacaine before induction of general anesthesia.

  • Superior Trunk Block Active comparatorSuperior Trunk Block

    Participants will receive an ultrasound-guided superior trunk block with 20 mL of 0.25% bupivacaine before induction of general anesthesia.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Incidence of Hemidiaphragmatic Paralysis Baseline (before block) and approximately 30 minutes after admission to the post-anesthesia care unit

    Ipsilateral diaphragmatic excursion will be measured with M-mode ultrasound during the sniff maneuver (mean of three measurements). Hemidiaphragmatic paralysis is defined as a ≥25% reduction in excursion from baseline and graded as none (\<25%), partial (25-75%), or complete (\>75% reduction or paradoxical movement).

Lead sponsor's other trials

Bursa Yuksek Ihtisas Training and Research Hospital, most recent start first.

Similar trials

Same condition (Humeral Fractures) and phase, most recent start first.